U.S. Food and Drug Administration (FDA) researchers are preparing to publish a study on a set of data that identified four potential issues in elderly persons after COVID-19 vaccination.
The FDA announced in July 2021 that near real-time surveillance detected four potential adverse events of interest following receipt of Pfizer’s vaccine.
The agency has given zero updates on the matter since then, until Sept. 30, when a spokesperson said that a study on the surveillance is expected to be published soon.
“The medical record review and statistical analyses have recently been completed, and the overall study results are currently under internal review at FDA,” the spokesperson told The Epoch Times via email. “Release of the study findings is expected later this fall.”…